Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
As of today, Pfizer(PFE) shares are valued at $25.47. The company's market cap stands at 144.76B, with a P/E ratio of 14.62 and a dividend yield of 6.8%.
On 2025-11-18, Pfizer(PFE) stock moved within a range of $24.92 to $25.50. With shares now at $25.47, the stock is trading +2.2% above its intraday low and -0.1% below the session's peak.
Trading activity shows a volume of 41.68M, compared to an average daily volume of 120.76M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.
PFE News
Pfizer Inc. (PFE) is returning to the U.S. debt markets with a fresh corporate bond offering aimed at raising at least $5 billion, Bloomberg reported. The proce...
Key Points Pfizer's CEO thinks his company will make big waves in the weight loss market. Eli Lilly does have a strong hold on the industry and won't let go a...
Healthcare stocks have far outperformed the broader market over the past month. The healthcare sector has been on fire in recent weeks. The S&P 500 Healthcare...
Analyst ratings
56%
of 27 ratingsMore PFE News
Key Points Pfizer is a $145 billion pharmaceutical industry giant with a long history of success behind it. Wall Street bid the stock up during the COVID-19 p...
Key Points Pfizer is buying out Metsera for up to $10 billion after an acquisition battle with another pharma giant. Metsera's leading candidate could be an e...
Pfizer (PFE) has been a topic of interest for investors, especially as its stock returned nearly 3% over the past month. Despite some ups and downs this year, t...
Jeffrey Smith’s Starboard Value disclosed in an SEC filing its holdings as of September 30, 2025. Starboard’s one new buys during the third quarter was Bill Hol...
Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...
Pfizer’s shares (PFE) edged higher on Thursday after shareholders of Metsera (MTSR) approved the American pharma giant’s offer of up to $10 billion to take over...
Pfizer (PFE) announced the successful completion of its acquisition of Metsera (MTSR). “Pfizer has completed its acquisition of all outstanding shares of common...